Galecto stockholders elect two Class II directors and ratify auditor at 2022 annual meeting

Damora Therapeutics, Inc.

Carl Goldfischer, M.D. elected with 11,025,408 votes for; David Shapiro, M.D. with 11,050,440 votes for.
Ratification of EY Godkendt Revisionspartnerselskab as independent auditor for FY2022: 15,589,293 for, 33,022 against.
15,647,815 shares represented at meeting out of 25,261,832 entitled to vote; 3,360,631 broker non-votes on director election.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.